FDA Issues Guidance for Remote Digital Pathology Devices
Increased availability of such devices may help to facilitate continuity of patient care by preventing disruptions to critical pathology services.
Increased availability of such devices may help to facilitate continuity of patient care by preventing disruptions to critical pathology services.
This month’s issue features anatomic and digital pathology technologies from such companies as BioGenex, Indica Labs, and MicroDimensions.
Advances in anatomic and digital pathology are enabling medical professionals to make more accurate diagnoses than ever before.